I. Casado
University of Barcelona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by I. Casado.
Neurology | 2007
M. Alonso de Leciñana; J.A. Egido; C. Fernández; Eduardo Martínez-Vila; S. Santos; A. Morales; Eva Martínez; A. Pareja; José Alvarez-Sabín; I. Casado
Background: Estrogen loss has been related to higher incidence of stroke in postmenopausal women, but randomized trials have demonstrated an increased risk of stroke in women receiving hormone replacement therapy (HRT). Objective: To assess the relationship between exposure to endogenous ovarian hormones and the risk of noncardioembolic ischemic stroke. Methods: We conducted a multicenter, age-matched, case-control study in postmenopausal women (case: nonembolic ischemic stroke; control: no stroke) comparing duration of ovarian activity or lifetime estrogen exposure, which was defined as age at menarche to age at menopause. Embolic cardiopathy and unreliable gynecologic data were exclusion criteria. Cardiovascular disease risk factors were recorded. The relationships of the principal variables to the risk of stroke were assessed using a conditional logistic regression analysis. Results: There were 430 cases and 905 controls in the study. In the multivariate analysis, hypertension (odds ratio [OR]: 2.73; 95% CI: 2.09 to 3.58; p < 0.0001), diabetes (OR: 3.38; 95% CI: 2.53 to 4.52; p < 0.0001), hyperlipidemia (OR: 1.31; 95% CI: 1.01 to 1.7; p = 0.045), lifespan of ovarian activity <34 years (OR: 1.51; 95% CI: 1.13 to 2.03; p = 0.005), and menarche at <13 years of age (OR 1.49; 95% CI: 1.15 to 1.92; p = 0.002) were independently related to an increased risk of stroke. Obesity (OR: 0.73; 95% CI: 0.56 to 0.95; p = 0.021) was related to a lower risk of stroke. Conclusions: Longer lifetime exposure to ovarian estrogens may protect against noncardioembolic ischemic stroke. However, a very early age of exposure onset could be disadvantageous.
Neurologia | 2013
Manuel Rodríguez-Yáñez; Mar Castellanos; M. Freijo; J.C. López Fernández; Joan Martí-Fàbregas; F. Nombela; P. Simal; J. Castillo; E. Díez-Tejedor; B. Fuentes; M. Alonso de Leciñana; José Alvarez-Sabín; Juan F. Arenillas; S. Calleja; I. Casado; A. Dávalos; F. Díaz-Otero; J.A. Egido; J. Gállego; A. García Pastor; A. Gil-Núñez; F. Gilo; Pablo Irimia; Aida Lago; J. Maestre; J. Masjuan; P. Martínez-Sánchez; Eduardo Martínez-Vila; C. Molina; A. Morales
Intracerebral haemorrhage accounts for 10%-15% of all strokes; however it has a poor prognosis with higher rates of morbidity and mortality. Neurological deterioration is often observed during the first hours after onset and determines poor prognosis. Intracerebral haemorrhage, therefore, is a neurological emergency which must be diagnosed and treated properly as soon as possible. In this guide we review the diagnostic procedures and factors that influence the prognosis of patients with intracerebral haemorrhage and we establish recommendations for the therapeutic strategy, systematic diagnosis, acute treatment and secondary prevention for this condition.
Neurologia | 2012
B. Fuentes; J. Gállego; A. Gil-Núñez; A. Morales; Francisco Purroy; Jaume Roquer; T. Segura; J. Tejada; Aida Lago; E. Díez-Tejedor; M. Alonso de Leciñana; José Alvarez-Sabín; Juan F. Arenillas; S. Calleja; I. Casado; Mar Castellanos; J. Castillo; A. Dávalos; F. Díaz-Otero; J.A. Egido; J.C. López-Fernández; M. Freijo; A. García Pastor; F. Gilo; Pablo Irimia; J. Maestre; J. Masjuan; Joan Martí-Fàbregas; P. Martínez-Sánchez; Eduardo Martínez-Vila
OBJECTIVE To update the ad hoc Committee of the Cerebrovascular Diseases Study Group of The Spanish Neurological Society guidelines on prevention of ischaemic stroke (IS) and transient ischaemic attack (TIA). METHODS We reviewed available evidence on risk factors and means of modifying them to prevent ischaemic stroke and TIA. Levels of evidence and recommendation grades are based on the classification of the Centre for Evidence-Based Medicine. RESULTS This first section summarises the recommendations for action on the following factors: blood pressure, diabetes, lipids, tobacco and alcohol consumption, diet and physical activity, cardio-embolic diseases, asymptomatic carotid stenosis, hormone replacement therapy and contraceptives, hyperhomocysteinemia, prothrombotic states and sleep apnea syndrome. CONCLUSIONS Changes in lifestyle and pharmacological treatment for hypertension, diabetes mellitus and dyslipidemia, according to criteria of primary and secondary prevention, are recommended for preventing ischemic stroke.
Neurologia | 2014
B. Fuentes; J. Gállego; A. Gil-Núñez; A. Morales; Francisco Purroy; Jaume Roquer; T. Segura; J. Tejada; Aida Lago; E. Díez-Tejedor; M. Alonso de Leciñana; José Alvarez-Sabín; Juan F. Arenillas; S. Calleja; I. Casado; Mar Castellanos; J. Castillo; A. Dávalos; F. Díaz-Otero; J.A. Egido; J.C. López-Fernández; M. Freijo; A. García Pastor; F. Gilo; Pablo Irimia; J. Maestre; J. Masjuan; Joan Martí-Fàbregas; P. Martínez-Sánchez; Eduardo Martínez-Vila
BACKGROUND AND OBJECTIVE To update the ad hoc Committee of the Cerebrovascular Diseases Study Group of The Spanish Neurological Society guidelines on prevention of ischaemic stroke (IS) and Transient Ischaemic Attack (TIA). METHODS We reviewed the available evidence on ischaemic stroke and TIA prevention according to aetiological subtype. Levels of evidence and recommendation levels are based on the classification of the Centre for Evidence-Based Medicine. RESULTS In atherothrombotic IS, antiplatelet therapy and revascularization procedures in selected cases of ipsilateral carotid stenosis (70%-90%) reduce the risk of recurrences. In cardioembolic IS (atrial fibrillation, valvular diseases, prosthetic valves and myocardial infarction with mural thrombus) prevention is based on the use of oral anticoagulants. Preventive therapies for uncommon causes of IS will depend on the aetiology. In the case of cerebral venous thrombosis oral anticoagulation is effective. CONCLUSIONS We conclude with recommendations for clinical practice in prevention of IS according to the aetiological subtype presented by the patient.
Science of The Total Environment | 2015
I. Casado; Himi Mahjoub; R. Lovera; Jesús Fernández; A. Casas
This study focuses on the uses of the electrical tomography and its relationship with hydrochemical data in order to characterize contaminated groundwater flows in fractured aquifers. The studied area is contaminated with different hazardous substances like lyndanes, organochlorinated compounds and benzenes coming from the old non-controlled Sardas landfill. The enormous volumes of wastes filling the landfill have generated a convoluted mixture of leachates. Due to the lack of a landfill liner, the leachates have migrated through the fractured Eocene marls towards the Gallego River. The striking correlation between high concentrations of polluted groundwater and low electrical resistivity of the subsurface (<8Ω·m) allows defining the principal contaminant migration route thanks to the distribution of these conductive anomalies. This mapping verifies that there is intense tectonical-structural control of the leachate migration, because the deep migration presents the same direction as the geological axis fold.
Neurologia | 2014
M. Alonso de Leciñana; J.A. Egido; I. Casado; Marc Ribo; A. Dávalos; J. Masjuan; J.L. Caniego; E. Martínez Vila; E. Díez Tejedor; B. Fuentes; José Alvarez-Sabín; Juan F. Arenillas; S. Calleja; Mar Castellanos; J. Castillo; F. Díaz-Otero; J.C. López-Fernández; M. Freijo; J. Gállego; A. García-Pastor; A. Gil-Núñez; F. Gilo; Pablo Irimia; Aida Lago; J. Maestre; Joan Martí-Fàbregas; P. Martínez-Sánchez; C. Molina; A. Morales; F. Nombela
Neurologia | 2006
José Alvarez-Sabín; M. Alonso de Leciñana; J. Gállego; Alberto Gil-Peralta; I. Casado; J. Castillo; E. Díez Tejedor; A. Gil; C. Jimenez; Aida Lago; Eduardo Martínez-Vila; A. Ortega; M. Rebollo; Francisco Rubio
Neurologia | 2014
M. Alonso de Leciñana; J.A. Egido; I. Casado; Marc Ribo; A. Dávalos; J. Masjuan; J.L. Caniego; E. Martínez Vila; E. Díez Tejedor; B. Fuentes; José Alvarez-Sabín; Juan F. Arenillas; S. Calleja; Mar Castellanos; José Castillo; F. Díaz-Otero; J.C. López-Fernández; M. Freijo; J. Gállego; A. García-Pastor; A. Gil-Núñez; F. Gilo; Pablo Irimia; Aida Lago; J. Maestre; Joan Martí-Fàbregas; P. Martínez-Sánchez; C. Molina; A. Morales; F. Nombela
Neurologia | 2013
Manuel Rodríguez-Yáñez; Mar Castellanos; M. Freijo; J.C. López Fernández; Joan Martí-Fàbregas; F. Nombela; P. Simal; José Castillo; E. Díez-Tejedor; B. Fuentes; M. Alonso de Leciñana; José Alvarez-Sabín; Juan F. Arenillas; S. Calleja; I. Casado; A. Dávalos; F. Díaz-Otero; J.A. Egido; J. Gállego; A. García Pastor; A. Gil-Núñez; F. Gilo; Pablo Irimia; Aida Lago; J. Maestre; J. Masjuan; P. Martínez-Sánchez; Eduardo Martínez-Vila; C. Molina; A. Morales
Neurologia | 2014
J. Vivancos; F. Gilo; R. Frutos; J. Maestre; A. García-Pastor; F. Quintana; J.M. Roda; Á. Ximénez-Carrillo; E. Díez Tejedor; B. Fuentes; M. Alonso de Leciñana; José Alvarez-Sabín; Juan F. Arenillas; S. Calleja; I. Casado; Mar Castellanos; José Castillo; A. Dávalos; F. Díaz-Otero; J.A. Egido; J.C. Fernández; M. Freijo; J. Gállego; A. Gil-Núñez; Pablo Irimia; Aida Lago; J. Masjuan; Joan Martí-Fàbregas; P. Martínez-Sánchez; Eduardo Martínez-Vila